SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

被引：32

作者：

Zaoutis, Theoklis ^{[1
,2
,3
]}

Lehrnbecher, Thomas ^{[4
]}

Groll, Andreas H. ^{[5
]}

Steinbach, William J. ^{[6
,7
]}

Jafri, Hasan S. ^{[8
]}

Maertens, Johan ^{[9
]}

Ngai, Angela L. ^{[10
,11
,12
]}

Chow, Joseph W. ^{[10
,11
,12
]}

Taylor, Arlene F. ^{[10
,11
,12
]}

Strohmaier, Kim M. ^{[10
,11
,12
]}

Bourque, Michael ^{[10
,11
,12
]}

Bradshaw, Susan K. ^{[10
,11
,12
]}

Petrecz, Maria ^{[10
,11
,12
]}

Kartsonis, Nicholas A. ^{[10
,11
,12
]}

机构：

[1] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA

[3] Univ Penn, Sch Med, Dept Pediat & Epidemiol, Philadelphia, PA 19104 USA

[4] Goethe Univ Frankfurt, Frankfurt, Germany

[5] Univ Childrens Hosp Muenster, Munster, Germany

[6] Duke Univ, Dept Pediat, Div Pediat Infect Dis, Durham, NC 27706 USA

[7] Duke Univ, Dept Mol Genet & Microbiol, Div Pediat Infect Dis, Durham, NC USA

[8] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Pediat Infect Dis, Dallas, TX 75390 USA

[9] Univ Hosp Gasthuisberg, Dept Hematol, B-3000 Leuven, Belgium

[10] Merck Res Labs, Dept Clin Res, West Point, PA USA

[11] Merck Res Labs, Dept Biostat, West Point, PA USA

[12] Merck Res Labs, Dept Med Commun, West Point, PA USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2009年 / 28卷 / 12期

关键词：

caspofungin; safety; invasive mycoses; empirical therapy; pediatric patients; AMPHOTERICIN-B;

D O I：

10.1097/INF.0b013e3181af5a15

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We analyzed the caspofungin safety experience in 5 clinical registration studies in 171 pediatric patients, I week to 17 years of age. Caspofungin was administered for I to 87 (mean 12.1) days. The most common drug-related adverse events were fever, increased AST, increased ALT, and rash; few events were serious or required treatment discontinuation. Caspofungin was well tolerated in this pediatric population.

引用

页码：1132 / 1135

页数：4

共 11 条

[1] Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
Abruzzo, GK
Flattery, AM
Gill, CJ
Kong, L
Smith, JG
Pikounis, VB
Balkovec, JM
Bouffard, AF
Dropinski, JF
Rosen, H
Kropp, H
Bartizal, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2333 - 2338
[2] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K
Gill, CJ
Abruzzo, GK
Flattery, AM
Kong, L
Scott, PM
Smith, JG
Leighton, CE
Bouffard, A
Dropinski, JF
Balkovec, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332
[3] MAERTENS J, 2007, 47 INT C ANT AG CHEM
[4] *MERCK CO INC, 2008, CANCIDAS CASP AC INJ
[5] Comparison of caspofungin and amphotericin B for invasive candidiasis.
Mora-Duarte, J
Betts, R
Rotstein, C
Colombo, AL
Thompson-Moya, L
Smietana, J
Lupinacci, R
Sable, C
Kartsonis, N
Perfect, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) : 2020 - 2029
[6] Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
Neely, Michael
Jafri, Hasan S.
Seibel, Nita
Knapp, Katherine
Adamson, Peter C.
Bradshaw, Susan K.
Strohmaier, Kim M.
Sun, Peng
Bi, Sheng
Dockendorf, Marissa Fallon
Stone, Julie A.
Kartsonis, Nicholas A.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1450 - 1456
[7] Sable C A, 2002, Transpl Infect Dis, V4, P25, DOI 10.1034/j.1399-3062.2002.01004.x
[8] Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
Saez-Llorens, Xavier
Macias, Mercedes
Maiya, Padmanabha
Pineros, Juan
Jafri, Hasan S.
Chatterjee, Archana
Ruiz, Gloria
Raghavan, Janaki
Bradshaw, Susan K.
Kartsonis, Nicholas A.
Sun, Peng
Strohmaier, Kim M.
Fallon, Marissa
Bi, Sheng
Stone, Julie A.
Chow, Joseph W.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 869 - 875
[9] Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
Walsh, TJ
Adamson, PC
Seibel, NL
Flynn, PM
Neely, MN
Schwartz, C
Shad, A
Kaplan, SL
Roden, MM
Stone, JA
Miller, A
Bradshaw, SK
Li, SX
Sable, CA
Kartsonis, NA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4536 - 4545
[10] Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
Walsh, TJ
Teppler, H
Donowitz, GR
Maertens, JA
Baden, LR
Dmoszynska, A
Cornely, OA
Bourque, MR
Lupinacci, RJ
Sable, CA
dePauw, BE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) : 1391 - 1402

← 1 2 →